Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

NCT02639767 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Pemetrexed/Cisplatin
RADIATION: Pleural Intensity Modulated Radiation Therapy
DEVICE: MRI

Sponsor

Memorial Sloan Kettering Cancer Center